| 000 | 01324 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516092154.0 | ||
| 264 | 0 | _c20120726 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1687-5303 | ||
| 024 | 7 |
_a10.1155/2012/635472 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForst, Thomas | |
| 245 | 0 | 0 |
_aCardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control. _h[electronic resource] |
| 260 |
_bExperimental diabetes research _c2012 |
||
| 300 |
_a635472 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xdrug therapy |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 700 | 1 | _aWeber, Matthias M | |
| 700 | 1 | _aPfützner, Andreas | |
| 773 | 0 |
_tExperimental diabetes research _gvol. 2012 _gp. 635472 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2012/635472 _zAvailable from publisher's website |
| 999 |
_c21773175 _d21773175 |
||